QSS
AQST icon

Quantitative Systematic Strategies’s Aquestive Therapeutics AQST Stock Holding History

Quantitative Systematic Strategies’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,441
Closed -$72K – 396
2018
Q4 		$72K Buy
+11,441
New +$144K 0.02% 632

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantitative Systematic Strategies's AQST Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of Aquestive Therapeutics (AQST) in Q1 2019, closing a stake of 11,441 shares — an estimated $72K sold.

Quantitative Systematic Strategies first reported a position in AQST in Q4 2018 and held it in 1 quarter. The position peaked at $72K in Q4 2018. 49 funds tracked by Wall St. Rank hold AQST as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining Aquestive Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 11,441 Aquestive Therapeutics shares in Q1 2019, an estimated $72K.
  • Quantitative Systematic Strategies first reported a position in Aquestive Therapeutics in Q4 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Aquestive Therapeutics position peaked at $72K in Q4 2018.
  • 49 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.